Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aadi Bioscience, Inc. stock logo
AADI
Aadi Bioscience
$1.99
+5.9%
$1.80
$1.21
$3.81
$49.15M0.68252,407 shs57,482 shs
Connect Biopharma Holdings Limited Sponsored ADR stock logo
CNTB
Connect Biopharma
$1.14
+5.1%
$0.87
$0.51
$1.60
$64.97M-0.256,862 shs148,655 shs
Frequency Therapeutics, Inc. stock logo
FREQ
Frequency Therapeutics
$0.30
$0.58
$0.18
$16.00
$10.94M0.84822,537 shs309,164 shs
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
$1.00
+1.0%
$0.98
$0.65
$1.75
$59.66M-0.02522,554 shs186,072 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aadi Bioscience, Inc. stock logo
AADI
Aadi Bioscience
0.00%+3.11%+17.75%+19.88%+42.14%
Connect Biopharma Holdings Limited Sponsored ADR stock logo
CNTB
Connect Biopharma
0.00%+13.50%+45.49%+80.16%-12.69%
Frequency Therapeutics, Inc. stock logo
FREQ
Frequency Therapeutics
0.00%0.00%0.00%0.00%0.00%
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
0.00%+2.40%0.00%+12.85%+99,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aadi Bioscience, Inc. stock logo
AADI
Aadi Bioscience
0.6468 of 5 stars
1.00.00.00.01.12.51.3
Connect Biopharma Holdings Limited Sponsored ADR stock logo
CNTB
Connect Biopharma
3.3244 of 5 stars
3.55.00.00.01.42.50.6
Frequency Therapeutics, Inc. stock logo
FREQ
Frequency Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
1.6462 of 5 stars
3.50.00.00.01.70.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aadi Bioscience, Inc. stock logo
AADI
Aadi Bioscience
2.00
Hold$1.67-16.25% Downside
Connect Biopharma Holdings Limited Sponsored ADR stock logo
CNTB
Connect Biopharma
3.00
Buy$7.00516.74% Upside
Frequency Therapeutics, Inc. stock logo
FREQ
Frequency Therapeutics
0.00
N/AN/AN/A
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
3.00
Buy$7.33633.33% Upside

Current Analyst Ratings Breakdown

Latest FREQ, CNTB, IRD, and AADI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/27/2025
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$8.00
6/12/2025
Connect Biopharma Holdings Limited Sponsored ADR stock logo
CNTB
Connect Biopharma
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy ➝ Buy$7.00
4/11/2025
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$6.00
(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aadi Bioscience, Inc. stock logo
AADI
Aadi Bioscience
$25.07M1.96N/AN/A$4.29 per share0.46
Connect Biopharma Holdings Limited Sponsored ADR stock logo
CNTB
Connect Biopharma
$26.03M2.42N/AN/A$1.67 per share0.68
Frequency Therapeutics, Inc. stock logo
FREQ
Frequency Therapeutics
$14.07M0.78N/AN/A$1.96 per share0.15
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
$13.65M4.37N/AN/A$0.21 per share4.76
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aadi Bioscience, Inc. stock logo
AADI
Aadi Bioscience
-$65.76M-$2.35N/AN/AN/A-246.06%-71.87%-57.28%8/5/2025 (Estimated)
Connect Biopharma Holdings Limited Sponsored ADR stock logo
CNTB
Connect Biopharma
-$15.63MN/A0.00N/AN/AN/AN/AN/A9/5/2025 (Estimated)
Frequency Therapeutics, Inc. stock logo
FREQ
Frequency Therapeutics
-$81.58M-$1.89N/AN/AN/AN/A-107.67%-61.40%N/A
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
-$57.53M-$2.10N/AN/AN/A-429.42%-283.28%-144.32%8/12/2025 (Estimated)

Latest FREQ, CNTB, IRD, and AADI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
Connect Biopharma Holdings Limited Sponsored ADR stock logo
CNTB
Connect Biopharma
-$0.26-$0.19+$0.07-$0.19N/AN/A
5/15/2025Q1 2025
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
-$0.34-$0.32+$0.02-$0.24$4.00 million$4.30 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aadi Bioscience, Inc. stock logo
AADI
Aadi Bioscience
N/AN/AN/AN/AN/A
Connect Biopharma Holdings Limited Sponsored ADR stock logo
CNTB
Connect Biopharma
N/AN/AN/AN/AN/A
Frequency Therapeutics, Inc. stock logo
FREQ
Frequency Therapeutics
N/AN/AN/AN/AN/A
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aadi Bioscience, Inc. stock logo
AADI
Aadi Bioscience
N/A
4.89
4.54
Connect Biopharma Holdings Limited Sponsored ADR stock logo
CNTB
Connect Biopharma
0.01
10.25
10.25
Frequency Therapeutics, Inc. stock logo
FREQ
Frequency Therapeutics
N/A
5.81
5.81
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
N/A
1.98
1.98

Institutional Ownership

CompanyInstitutional Ownership
Aadi Bioscience, Inc. stock logo
AADI
Aadi Bioscience
52.08%
Connect Biopharma Holdings Limited Sponsored ADR stock logo
CNTB
Connect Biopharma
58.72%
Frequency Therapeutics, Inc. stock logo
FREQ
Frequency Therapeutics
13.18%
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
14.97%

Insider Ownership

CompanyInsider Ownership
Aadi Bioscience, Inc. stock logo
AADI
Aadi Bioscience
37.30%
Connect Biopharma Holdings Limited Sponsored ADR stock logo
CNTB
Connect Biopharma
22.60%
Frequency Therapeutics, Inc. stock logo
FREQ
Frequency Therapeutics
16.80%
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
6.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aadi Bioscience, Inc. stock logo
AADI
Aadi Bioscience
4024.70 million15.49 millionOptionable
Connect Biopharma Holdings Limited Sponsored ADR stock logo
CNTB
Connect Biopharma
11055.56 million43.00 millionOptionable
Frequency Therapeutics, Inc. stock logo
FREQ
Frequency Therapeutics
4636.52 million30.39 millionNot Optionable
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
1459.66 million55.72 millionN/A

Recent News About These Companies

Opus Genetics (NASDAQ:IRD) Earns "Buy" Rating from HC Wainwright
Opus Genetics (NASDAQ:IRD) Cut to "Sell" at Wall Street Zen
IRD Opus Genetics, Inc.

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Aadi Bioscience stock logo

Aadi Bioscience NASDAQ:AADI

$1.99 +0.11 (+5.85%)
As of 07/3/2025

Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa. The company is also involved in evaluating FYARRO in cancers, including indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.

Connect Biopharma stock logo

Connect Biopharma NASDAQ:CNTB

$1.14 +0.06 (+5.09%)
As of 07/3/2025 03:47 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. The company is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets. Its lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma, currently under Phase 3 studies; and icanbelimod (formerly CBP-307), an oral small molecule Sphingosine 1-Phosphate Receptor 1 modulator, currently under Phase 2 clinical for the treatment of ulcerative colitis and Crohn's disease. The company was founded in 2012 and is based in San Diego, California.

Frequency Therapeutics stock logo

Frequency Therapeutics NASDAQ:FREQ

Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules to activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIb clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. The company has a license and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322, as well as collaboration and licensing agreements with Massachusetts Eye and Ear, the Massachusetts Institute of Technology, and The Scripps Research Institute. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts.

Opus Genetics stock logo

Opus Genetics NASDAQ:IRD

$1.00 +0.01 (+1.01%)
Closing price 07/3/2025 03:44 PM Eastern
Extended Trading
$0.98 -0.02 (-1.50%)
As of 07/3/2025 04:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Opus Genetics Inc. is a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. Opus Genetics Inc., formerly known as Ocuphire Pharma Inc., is based in Farmington Hills, Michigan.